Lack of functionality and need for revision of an Ommaya reservoir placed into a cavum septum pellucidum

Case report

View More View Less
  • Department of Neurosurgery, Mount Sinai Hospital, New York, New York
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Ommaya reservoirs are routinely placed for the administration of intrathecal chemotherapy or antibiotics. There is scant literature that addresses the functionality of an Ommaya catheter placed exclusively within a cavum septum pellucidum (CSP). In this case, the authors placed an Ommaya reservoir in a 30-year-old man with Burkitt lymphoma in the CNS for intrathecal chemotherapy. The catheter tip was placed within a large CSP. The authors demonstrated failure of the system by injecting contrast agent into the reservoir and obtaining immediate and delayed CT scans that failed to demonstrate contrast dissemination into the ventricular system. An Ommaya reservoir placed exclusively within a CSP is potentially not functional, and can be dangerous if used for intrathecal drug therapy.

Abbreviations used in this paper:CSP = cavum septum pellucidum; CV = cavum vergae; EVD = external ventricular drain.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Justin R. Mascitelli, M.D., Department of Neurosurgery, Mount Sinai Medical Center, One Gustave L. Levy Place, Annenberg Building 8, Box 1136, New York, New York 10029. email: jmascite@gmail.com.

Please include this information when citing this paper: published online November 2, 2012; DOI: 10.3171/2012.10.JNS12818.

  • 1

    Feletti A, , Denaro L, , Faggin R, , Ciccarino P, , Rossetto M, & d'Avella D: Cavum septi pellucidi and external ventricular drain failure. Case illustration. J Neurosurg Pediatr 8:39, 2011

    • Search Google Scholar
    • Export Citation
  • 2

    Mapstone TB, & White RJ: Cavum septi pellucidi as a cause of shunt dysfunction. Surg Neurol 16:9698, 1981

  • 3

    Ommaya AK: Implantable devices for chronic access and drug delivery to the central nervous system. Cancer Drug Deliv 1:169179, 1984

  • 4

    Oteruelo FT: On the cavum septi pellucidi and the cavum Vergae. Anat Anz 162:271278, 1986

  • 5

    Pearce JM: Some observations on the septum pellucidum. Eur Neurol 59:332334, 2008

  • 6

    Ronsin E, , Grosskopf D, & Perre J: Morphology and immunohistochemistry of a symptomatic septum pellucidum cavum Vergae cyst in man. Acta Neurochir (Wien) 139:366372, 1997

    • Search Google Scholar
    • Export Citation
  • 7

    Sencer A, , Sencer S, , Turantan I, & Devecioğlu O: Cerebrospinal fluid dynamics of the cava septi pellucidi and vergae. Case report. J Neurosurg 94:127129, 2001

    • Search Google Scholar
    • Export Citation
  • 8

    Sherman PM, & Aygun N: Development of a cavum septi pellucidi after Ommaya reservoir placement: report of an unusual complication. Acta Neurochir (Wien) 148:359362, 2006

    • Search Google Scholar
    • Export Citation
  • 9

    Tubbs RS, , Krishnamurthy S, , Verma K, , Shoja MM, , Loukas M, & Mortazavi MM, : Cavum velum interpositum, cavum septum pellucidum, and cavum vergae: a review. Childs Nerv Syst 27:19271930, 2011

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 437 83 10
Full Text Views 150 7 1
PDF Downloads 147 4 0
EPUB Downloads 0 0 0